Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Avramides A., Flores A., DeRose J., Wallach S. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment. J Clin Endocrinol Metab. 1976 Mar;42(3):459–463. doi: 10.1210/jcem-42-3-459. [DOI] [PubMed] [Google Scholar]
- Bijvoet O. L., Frijlink W. B., Jie K., van der Linden H., Meijer C. J., Mulder H., van Paassen H. C., Reitsma P. H., te Velde J., de Vries E. APD in Paget's disease of bone. Role of the mononuclear phagocyte system? Arthritis Rheum. 1980 Oct;23(10):1193–1204. doi: 10.1002/art.1780231018. [DOI] [PubMed] [Google Scholar]
- Bouvet J. P. Traitement de la maladie de Paget par la thyrocalcitonine de saumon. Etude coopérative en double insu. Nouv Presse Med. 1976 Apr 23;6(17):1447–1450. [PubMed] [Google Scholar]
- Canfield R., Rosner W., Skinner J., McWhorter J., Resnick L., Feldman F., Kammerman S., Ryan K., Kunigonis M., Bohne W. Diphosphonate therapy of paget's disease of bone. J Clin Endocrinol Metab. 1977 Jan;44(1):96–106. doi: 10.1210/jcem-44-1-96. [DOI] [PubMed] [Google Scholar]
- Fleisch H. Experimental basis for the clinical use of diphosphonates in Paget's disease of bone. Arthritis Rheum. 1980 Oct;23(10):1162–1171. doi: 10.1002/art.1780231014. [DOI] [PubMed] [Google Scholar]
- Frijlink W. B., Bijvoet O. L., te Velde J., Heynen G. Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). Lancet. 1979 Apr 14;1(8120):799–803. doi: 10.1016/s0140-6736(79)91318-7. [DOI] [PubMed] [Google Scholar]
- Haddad J. G., Jr, Caldwell J. G. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins. J Clin Invest. 1972 Dec;51(12):3133–3141. doi: 10.1172/JCI107140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hosking D. J., Bijvoet O. L., van Aken J., Will E. J. Paget's bone disease treated with diphosphonate and calcitonin. Lancet. 1976 Mar 20;1(7960):615–617. doi: 10.1016/s0140-6736(76)90420-7. [DOI] [PubMed] [Google Scholar]
- Johnston C. C., Jr, Khairi M. R., Meunier P. J. Use of etidronate (EHDP) in Paget's disease of bone. Arthritis Rheum. 1980 Oct;23(10):1172–1176. doi: 10.1002/art.1780231015. [DOI] [PubMed] [Google Scholar]
- Kanis J. A., Horn D. B., Scott R. D., Strong J. A. Treatment of Paget's disease of bone with synthetic salmon calcitonin. Br Med J. 1974 Sep 21;3(5933):727–731. doi: 10.1136/bmj.3.5933.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khairi M. R., Altman R. D., DeRosa G. P., Zimmermann J., Schenk R. K., Johnston C. C. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. Ann Intern Med. 1977 Dec;87(6):656–663. doi: 10.7326/0003-4819-87-6-656. [DOI] [PubMed] [Google Scholar]
- MacIntyre I., Evans I. M., Hobitz H. H., Joplin G. F., Stevenson J. C. Chemistry, physiology, and therapeutic applications of calcitonin. Arthritis Rheum. 1980 Oct;23(10):1139–1147. doi: 10.1002/art.1780231011. [DOI] [PubMed] [Google Scholar]
- Martin T. J., Jerums G., Melick R. A., Xipell J. M., Arnott R. Clinical, biochemical and histological observations on the effect of porcine calcitonin in Paget's disease of bone. Aust N Z J Med. 1977 Feb;7(1):36–43. doi: 10.1111/j.1445-5994.1977.tb03354.x. [DOI] [PubMed] [Google Scholar]
- Meunier P. J., Chapuy M. C., Alexandre C., Bressot C., Edouard C., Vignon C., Mathieu L., Trechsel U. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone. Lancet. 1979 Sep 8;2(8141):489–492. doi: 10.1016/s0140-6736(79)91551-4. [DOI] [PubMed] [Google Scholar]
- Mills B. G., Singer F. R. Nuclear inclusions in Paget's disease of bone. Science. 1976 Oct 8;194(4261):201–202. doi: 10.1126/science.959849. [DOI] [PubMed] [Google Scholar]
- Mills B. G., Singer F. R., Weiner L. P., Holst P. A. Cell cultures from bone affected by Paget's disease. Arthritis Rheum. 1980 Oct;23(10):1115–1120. doi: 10.1002/art.1780231007. [DOI] [PubMed] [Google Scholar]
- Parfitt A. M. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological and kinetic approaches to bone turnover. Metabolism. 1976 Jul;25(7):809–844. doi: 10.1016/0026-0495(76)90151-7. [DOI] [PubMed] [Google Scholar]
- Raine C. S., Feldman L. A., Sheppard R. D., Barbosa L. H., Bornstein M. B. Subacute sclerosing panencephalitis virus. Observations on a neuroadapted and non-neuroadapted strain in organotypic central nervous system cultures. Lab Invest. 1974 Jul;31(1):42–53. [PubMed] [Google Scholar]
- Rebel A., Basle M., Pouplard A., Malkani K., Filmon R., Lepatezour A. Bone tissue in Paget's disease of bone. Ultrastructure and Immunocytology. Arthritis Rheum. 1980 Oct;23(10):1104–1114. doi: 10.1002/art.1780231006. [DOI] [PubMed] [Google Scholar]
- Rebel A., Malkani K., Baslé M., Bregeon C. Osteoclast ultrastructure in Paget's disease. Calcif Tissue Res. 1976 Apr 20;(2):187–199. doi: 10.1007/BF02546407. [DOI] [PubMed] [Google Scholar]
- Singer F. R., Aldred J. P., Neer R. M., Krane S. M., Potts J. T., Jr, Bloch K. J. An evaluation of antibodies and clinical resistance to salmon calcitonin. J Clin Invest. 1972 Sep;51(9):2331–2338. doi: 10.1172/JCI107044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singer F. R., Fredericks R. S., Minkin C. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance. Arthritis Rheum. 1980 Oct;23(10):1148–1154. doi: 10.1002/art.1780231012. [DOI] [PubMed] [Google Scholar]
- Siris E. S., Canfield R. E., Jacobs T. P., Baquiran D. C. Long-term therapy of Paget's disease of bone with EHDP. Arthritis Rheum. 1980 Oct;23(10):1177–1184. doi: 10.1002/art.1780231016. [DOI] [PubMed] [Google Scholar]